SI1718337T1 - Nove kombinacije antagonista receptorja 5-HT3 z racecadotrilom ali deksecadotrilom - Google Patents

Nove kombinacije antagonista receptorja 5-HT3 z racecadotrilom ali deksecadotrilom

Info

Publication number
SI1718337T1
SI1718337T1 SI200531056T SI200531056T SI1718337T1 SI 1718337 T1 SI1718337 T1 SI 1718337T1 SI 200531056 T SI200531056 T SI 200531056T SI 200531056 T SI200531056 T SI 200531056T SI 1718337 T1 SI1718337 T1 SI 1718337T1
Authority
SI
Slovenia
Prior art keywords
dexecadotril
racecadotril
receptor antagonist
new combinations
combinations
Prior art date
Application number
SI200531056T
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1718337(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of SI1718337T1 publication Critical patent/SI1718337T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SI200531056T 2004-02-12 2005-02-14 Nove kombinacije antagonista receptorja 5-HT3 z racecadotrilom ali deksecadotrilom SI1718337T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor
PCT/IB2005/000351 WO2005079850A1 (en) 2004-02-12 2005-02-14 New combinations of an anti emetic agent and an enkephalinase inhibitor
EP05702484A EP1718337B1 (en) 2004-02-12 2005-02-14 New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril

Publications (1)

Publication Number Publication Date
SI1718337T1 true SI1718337T1 (sl) 2010-08-31

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531056T SI1718337T1 (sl) 2004-02-12 2005-02-14 Nove kombinacije antagonista receptorja 5-HT3 z racecadotrilom ali deksecadotrilom

Country Status (28)

Country Link
US (1) US8222294B2 (sl)
EP (2) EP1563848A1 (sl)
JP (1) JP4987487B2 (sl)
KR (1) KR101152308B1 (sl)
CN (1) CN1917903B (sl)
AT (1) ATE468138T1 (sl)
AU (1) AU2005215262B2 (sl)
BR (1) BRPI0506631B8 (sl)
CA (1) CA2553827C (sl)
CY (1) CY1110202T1 (sl)
DE (1) DE602005021317D1 (sl)
DK (1) DK1718337T3 (sl)
EA (1) EA010625B1 (sl)
EC (1) ECSP066758A (sl)
ES (1) ES2344909T3 (sl)
HR (1) HRP20100363T1 (sl)
MA (1) MA28354A1 (sl)
ME (1) ME01175B (sl)
NO (1) NO337320B1 (sl)
NZ (1) NZ548635A (sl)
PL (1) PL1718337T3 (sl)
PT (1) PT1718337E (sl)
RS (1) RS51329B (sl)
SI (1) SI1718337T1 (sl)
TN (1) TNSN06246A1 (sl)
UA (1) UA88156C2 (sl)
WO (1) WO2005079850A1 (sl)
ZA (1) ZA200605872B (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CA2877724A1 (en) * 2012-06-28 2014-01-03 Der-Yang Lee Racecadotril liquid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
SG11201408509PA (en) 2012-06-28 2015-01-29 Mcneil Ppc Inc Racecadotril lipid compositions
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
PL1718337T3 (pl) 2010-09-30
AU2005215262A1 (en) 2005-09-01
EA200601466A1 (ru) 2006-12-29
UA88156C2 (ru) 2009-09-25
CN1917903B (zh) 2010-07-21
ECSP066758A (es) 2006-11-24
PT1718337E (pt) 2010-06-16
JP4987487B2 (ja) 2012-07-25
DE602005021317D1 (de) 2010-07-01
ES2344909T3 (es) 2010-09-09
TNSN06246A1 (fr) 2007-12-03
DK1718337T3 (da) 2010-07-26
US20070275993A1 (en) 2007-11-29
EP1563848A1 (en) 2005-08-17
CA2553827C (en) 2012-08-07
EP1718337A1 (en) 2006-11-08
BRPI0506631A (pt) 2007-05-08
WO2005079850A1 (en) 2005-09-01
JP2007522202A (ja) 2007-08-09
EP1718337B1 (en) 2010-05-19
CY1110202T1 (el) 2015-01-14
EA010625B1 (ru) 2008-10-30
US8222294B2 (en) 2012-07-17
HRP20100363T1 (hr) 2010-07-31
NO337320B1 (no) 2016-03-07
BRPI0506631B1 (pt) 2018-12-04
ZA200605872B (en) 2008-01-08
KR20060132691A (ko) 2006-12-21
NZ548635A (en) 2009-10-30
RS51329B (en) 2011-02-28
NO20063973L (no) 2006-09-05
AU2005215262B2 (en) 2011-03-03
ME01175B (me) 2013-03-20
KR101152308B1 (ko) 2012-06-11
MA28354A1 (fr) 2006-12-01
CA2553827A1 (en) 2005-09-01
CN1917903A (zh) 2007-02-21
ATE468138T1 (de) 2010-06-15
BRPI0506631B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
PL1718337T3 (pl) Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem
DE602005023333D1 (de) Kinaseinhibitoren
DK1836201T4 (da) Pyrrolidininhibitorer af IAP.
MY146989A (en) Kinase inhibitors
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
PT2260875E (pt) Agentes de imagiologia direcionados para recetor de folato
WO2009089260A3 (en) Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
MY133335A (en) Photoresist compositions
MX2009005217A (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos.
UA85505C2 (en) Kinase inhibitors
EA200870097A1 (ru) Композиция полипропилена, включающая компонент сополимера пропилена
HK1131730A1 (en) Reducing side effects of tramadol
NO20070211L (no) Kationiske polymerer som inneholder 2-hydroksyetyl-metakrylsyre som akseleratorer for ASA-liming
TN2009000091A1 (en) Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
MX2009004269A (es) Inhibidores de cinasa mapk/erk.
DE602004019697D1 (de) Ep2-rezeptoragonisten
TW200633998A (en) Substituted heterocyclic compounds and thrombopoietin receptor activators
WO2009114856A3 (en) Aurora kinase inhibitors
TW200745187A (en) Protecting agent
RU2006141319A (ru) Ингибитор сероводородной коррозии стали
WO2007002842A3 (en) Substituted n-cinnamyl benzamides
TN2009000008A1 (en) Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
GB0422152D0 (en) Containers for the distribution of chemicals
WO2003072842A3 (en) Quenching device for two or more workpieces
TW200615292A (en) Additives for epoxy resins